Pronounce: EYE sa TUX i mab
Classification: Monoclonal Antibody
Isatuximab-irfc is a monoclonal antibody. Monoclonal antibodies are made in a lab to attach to the targets found on certain types of cancer cells. The antibody “calls” the immune system to attack the cell it is attached to, causing the immune system to kill the cell. These antibodies can work in different ways, such as by stimulating (revving up) the immune system to kill the cell, blocking cell growth or other things needed for cell growth.
Isatuximab-irfc is an antibody directed against a protein called CD38, found on the surface of multiple myeloma cells. Once isatuximab-irfc attaches itself to the cells that have CD38, it tells the body's immune system to attack and kill those cells.
Isatuximab-irfc is given by intravenous infusion (IV, into a vein). The dose and how often you receive this medication will be decided by your provider.
Medications are given before and after the infusion to prevent reactions to this medicine. These medications include:
Isatuximab-irfc can affect blood type testing (cross-matching and antibody screening). If you need a blood transfusion, be sure your provider and the blood bank know you have received this medication. A type and screen (blood test to check what type of blood you have) may be done before treatment with isatuximab-irfc.
There are a number of things you can do to manage the side effect of isatuximab-irfc. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
Your red blood cells are responsible for carrying oxygen to the tissues in your body. When the red cell count is low, you may feel tired or weak. You should let your oncology care team know if you experience any shortness of breath, difficulty breathing, or pain in your chest. If the count gets too low, you may receive a blood transfusion.
This medication can cause life-threatening infections, with or without a decrease in white blood cell counts.
White blood cells (WBC) are important for fighting infection. While receiving treatment, your WBC count can drop, putting you at a higher risk of getting an infection. You should let your doctor or nurse know right away if you have a fever (temperature greater than 100.4°F or 38°C), sore throat or cold, shortness of breath, cough, burning with urination, or a sore that doesn't heal.
Tips for preventing infection:
Platelets help your blood clot, so when the count is low you are at a higher risk of bleeding. Let your oncology care team know if you have any excess bruising or bleeding, including nose bleeds, bleeding gums, or blood in your urine or stool. If the platelet count becomes too low, you may receive a transfusion of platelets.
The infusion can cause a reaction that may lead to shortness of breath, chills, fever, high blood pressure, nausea, and vomiting. You will receive steroids, acetaminophen, heartburn medication, and diphenhydramine prior to the infusion to help prevent these reactions. Your oncology care team will tell you what to do if this happens.
This medication can cause pneumonia or upper respiratory infection. Report coughing, shortness of breath, and fever to your oncology care team.
Your oncology care team can recommend medications to relieve diarrhea. Also, try eating low-fiber, bland foods, such as white rice and boiled or baked chicken. Avoid raw fruits, vegetables, whole-grain bread, cereals, and seeds. Soluble fiber is found in some foods and absorbs fluid, which can help relieve diarrhea. Foods high in soluble fiber include applesauce, bananas (ripe), canned fruit, orange sections, boiled potatoes, white rice, products made with white flour, oatmeal, cream of rice, cream of wheat, and farina. Drink 8-10 glasses of non-alcoholic, un-caffeinated fluid a day to prevent dehydration.
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary during treatment and for at least 5 months after treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should not breastfeed while receiving this medication.
This medication is given in combination with pomalidomide which can also cause serious birth defects. Talk with your care team about this medication.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania